Sponsor pipeline

Leland Metheny clinical trial pipeline

Get alerts when Leland Metheny's trials change

2 active trials 2 recruiting 3 disease areas 5 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-11
Recruitment suspended
Recruitment suspended: insufficient funding
NCT06680661 ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis · Phase 2
2026-09-11
Primary completion pushed: 2025-11 → 2026-11
NCT03104491 Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia · Phase 1/2
2026-09-11
Primary completion pushed: 2026-06-01 → 2026-11-01
Completion pushed: 2026-12-01 → 2027-03-01
NCT05052957 hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · Phase 2

Active trials by phase

Phase 1/2
1
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT05052957 hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) Glioblastoma Multiforme Recruiting 2026-09-10
Phase 1/2
NCT03104491 Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia Acute Lymphocytic Leukemia Recruiting 2026-09-10

Disease areas by active trials

Acute Lymphoblastic Leukemia (ALL) (1) · Glioblastoma (1) · Leukemia (1)

Get alerts when Leland Metheny's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free